Acute prolonged neurotoxicity associated with recommended doses of ertapenem in 2 patients with advanced renal failure.

@article{Wen2013AcutePN,
  title={Acute prolonged neurotoxicity associated with recommended doses of ertapenem in 2 patients with advanced renal failure.},
  author={Min-jie Wen and Chih-Chien Sung and Tom Chau and Shih-Hua Lin},
  journal={Clinical nephrology},
  year={2013},
  volume={80 6},
  pages={474-8}
}
Ertapenem, a novel carbapenem with long-acting antimicrobial activity, is predominantly eliminated by the kidneys. Acute prolonged neurotoxicity associated with recommended doses of ertapenem in patients with advanced renal failure not yet on dialysis has not been reported. Two patients with Stage 5 chronic kidney disease (CKD) developed progressive hallucinations, asterixis, myoclonic jerks, and cognitive impairment after receiving the recommended dose reduction for CKD of ertapenem (500 mg/d… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…